Emeritus Research (ABN 34 091 996 575) is an independent clinical research centre based in Melbourne, Australia. With experience from Phase Ib to IV, we have successfully conducted in excess of 230 clinical trials across a range of indications that encompass two key therapeutic area pillars – Inflammatory Conditions and Lifestyle Diseases. From novel molecules to blockbuster drugs, our clinical trial experience is not just restricted to medicines that treat and prevent chronic and acute illness. We also have comprehensive capabilities in medical device and diagnostic studies too.
We are committed to bringing the highest scientific excellence to every trial, to expediting medical advances to patients in need and to maximising the return on resource investment for each client. We have partnered with over 60 local and international biopharmaceutical companies and contract research organisations and over 5,000 people to deliver globally transferable data for multi-region regulatory applications, indication extensions and pharmacoeconomic and post-marketing strategy analysis. Our vision is to be recognised within Australia and internationally for our excellence, commitment and capabilities in clinical research.